Merger Agreement Signed for state of the art 58,000 square foot manufacturing facility located in the Coachillin’ Industrial Canna Business Park known as “The Plant” for: NutraNomics Inc. (Stock Symbol: NNRX)
– Global Wellness Products Supplier On-Track for Growth via Acquisitions.
– Pending Acquisition of DHS Development, Inc. dba The Plant for Premium Quality Botanical Wellness Products.
– Plans to Provide Procurement, Extraction & Processing, Product Development, Contract Manufacturing and Contract Packaging.
– Acquisition Facility Conveniently Located Just Outside of LA in a Jurisdiction with ZERO Manufacturing Tax.
NutraNomics Inc. (OTC: NNRX) was incorporated in 2007 and quickly grew to achieve global success with its outstanding reputation of individual health support featuring its own nutraceutical products. Today, NNRX is more driven than ever to serve and support alternative health needs for all individuals. The NNRX mission is to provide products for organic health needs and health solutions in healing is focused on expanding market share by acquiring and alliances that play a pivotal role in stimulating the growth of companies that provide specialized product solutions.
All of the products NNRX features are designed to give each customer alternative options that are 100% organic, highly potent and intensely acute in providing healing benefits throughout all markets. Targets include: alliances, acquisitions and continuing to provide our high quality blends with proven trade secrets in healing of heart disease, cancer, type 2 diabetes, obesity, and arthritis, all of which are among the most common, costly, and preventable of all health problems.
– Acquisition of The Plant for Botanical Wellness Product Development, Production and Service
NutraNomics, Inc. (Stock Symbol: NNRX) is pleased to announce that it has signed a definitive merger agreement related to the acquisition of DHS Development, Inc. dba The Plant, of Desert Hot Springs, CA. The parties anticipate exchanging closing deliverables to officially close the acquisition in the coming days. The agreement contemplates the purchase of 100% of The Plant’s assets, operations and IP. As such, DHS Development, Inc. dba The Plant will be operated as a wholly-owned subsidiary of NutraNomics, Inc., and all applicable CA State licensing and regulatory credentials will remain under DHS Development, Inc. dba The Plant as a California-based company. With this acquisition, NutraNomics and The Plant will combine resources and strive to become an industry leader in the research, development and manufacture of plant-based products to the California market, with large production capabilities designed for efficient, low-cost production and scalability. The combined management team and key personnel combine for more than forty years of experience in cannabis cultivation, extraction, manufacturing, and product innovation.
Acquisition assets include California licensing for cannabis cultivation, manufacturing, and distribution, including an active Type 7 manufacturing license which allows for extraction practices utilizing volatile, non-volatile and solventless extraction methods, including additional post-processing activities. As California’s most robust manufacturing license type, the Type 7 license enables holders to perform all types of extraction and manufacturing practices, providing bearers with a definitive level of differentiation in the California market. Empowered by the NutraNomics capital infusion, The Plant is investing in necessary equipment that will enable broad production capabilities for innovative formulation and delivery methods. Production capabilities include a highly diverse array of innovative product categories including capsules, tablets, beverage products, concentrates, edibles, inhalables and topicals. In addition to production capabilities across most product types, complimentary manufacturing services are also available such as white label and private label development, contract packaging, biomass sourcing, full distribution services and R&D.
NNRX will assume the lease of a newly constructed, state of the art 58,000 square foot manufacturing and cultivation facility located in the Coachillin’ Industrial Cultivation & Ancillary Canna Business Park, located in Desert Hot Springs, California. The new 27,000 square foot manufacturing space ensures the Company will be ideally situated for expansion and scalability. Full manufacturing capacity is expected to be reached by mid-summer 2022 at the current rate of growth, and the 29,000 square foot cultivation facility is expected to be complete and operational by August 2022.
“On behalf of NNRX, I am thrilled that we’ve reached finalization of our acquisition of The Plant and are getting to the important work of building our Company in collaboration with the fine folks of The Plant,” says Jonathan Bishop, NutraNomics CEO and Chairman. “As an initial acquisition, this is an amazing opportunity for NutraNomics and The Plant personnel, customers, alliances, and investors to participate in the establishment of a strong foundation for growth, and an effective basis for future M&A’s to come. The past few months of working with The Plant principles has been key to our full appreciation of the value of this alliance. As such, we are excited to introduce our new team members in the days to come. This transaction represents a methodical and responsible action in our pursuit to acquire complementary resources in the Seed, Science, Processing and Distribution model that NutraNomics continues to target, as we look forward to bringing our shareholders the greatest growth in NutraNomics history.”
Current Services of The Plant Include:
– Extraction & Processing
– Product Development
– Contract Manufacturing
– Contract Packaging
For more information on NutraNomics Inc. (OTC: NNRX) visit: https://nutranomics.com.
DISCLAIMER: FrontPageStocks/CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. FPS/CA is NOT affiliated in any manner with any company mentioned herein. FPS/CA is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FPS/CA’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. FPS/ CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. FPS/CA has been compensated $500 by the company for dissemination of this Article.
These news releases and postings may contain forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.